Aclaris Therapeutics, Inc.
USD5.01
-0.01 (-0.20%)
CEO
Neal S. Walker
IPO Date
2015-10-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.99
Prev. Close
$5.02
Day Low
$4.94
Day High
$5.03
52W Low
$1.38
52W High
$5.15
Market Cap
$0.60B
Volume
0.13M
| -1.5 |
| 31 Dec 2023 | FY | 42.1% | -283.1% | -56.3% | -44.8% | 0.00 | 4.16 | -0.8 |
| 31 Dec 2022 | FY | 59.8% | -292.1% | -44.0% | -34.1% | 0.00 | 10.55 | -11.8 |
| 31 Dec 2021 | FY | 30.3% | -1344.0% | -46.0% | -36.2% | 0.00 | 8.94 | -9.1 |
| 31 Dec 2020 | FY | 20.8% | -787.0% | -135.5% | -72.1% | 0.30 | 3.87 | -5.4 |
| 31 Dec 2019 | FY | 4.1% | -3817.2% | -230.8% | -164.1% | 0.01 | 3.74 | -0.5 |
| 31 Dec 2018 | FY | 32.1% | -1315.4% | -61.7% | -48.2% | 0.14 | 6.56 | -1.8 |
| 31 Dec 2017 | FY | 28.3% | -4071.5% | -30.4% | -28.1% | 0.00 | 16.37 | -10.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -28.4% | -27.3% | 0.00 | 27.98 | -12.1 |
| -4.7 |
| 30 Sept 2025 | Q3 | 83.7% | -443.0% | -12.2% | -8.3% | 0.02 | 3.92 | -4.0 |
| 30 Jun 2025 | Q2 | -4.1% | -868.3% | -11.7% | -8.2% | 0.00 | 3.88 | -2.8 |
| 31 Mar 2025 | Q1 | 65.2% | -1036.8% | -10.5% | -7.6% | 0.00 | 5.06 | -3.1 |
| 31 Dec 2024 | Q4 | -1.0% | -1048.2% | -62.1% | -43.8% | 0.00 | 3.99 | -0.6 |
| 30 Sept 2024 | Q3 | 44.6% | -174.6% | -5.8% | -4.2% | 0.00 | 7.03 | -2.7 |
| 30 Jun 2024 | Q2 | 31.0% | -397.2% | -8.2% | -6.8% | 0.00 | 7.50 | -1.9 |
| 31 Mar 2024 | Q1 | 23.3% | -706.5% | -11.9% | -9.7% | 0.00 | 6.74 | -1.3 |
| 31 Dec 2023 | Q4 | 63.4% | -8.5% | -0.9% | -0.8% | 0.00 | 4.16 | -12.5 |